Leading up to Immunogenicity for Biotherapeutics this April 17-19, 2012 in Washington, DC, we'll be highlighting some of the key sessions at this year's conference. For more information on this session and the rest of the program, download the brochure.Enzyme replacement therapy is among the very few areas where the true causes of immune response have been well-studied and correlated to specific therapies. It is an extremely valuable window into the understanding of immune function for everyone who works in this field. Today, we're looking at "Immune Responses to Recombinant Protein Therapeutics: Lessons From Enzyme-Replacement Therapy for Lysosomal Storage Diseases".
Featured Session: Immune Responses to Recombinant Protein Therapeutics: Lessons From Enzyme-Replacement Therapy for Lysosomal Storage Diseases
Featured Speakers: Lorne Clarke, Professor of Medical Genetics, UNIVERSITY OF BRITISH COLUMBIA
Priya Kishnani, MD, Division Chief, Medical Genetics, DUKE MEDICINE
About the session:
•Apply lessons from lysosomal storage disease treatment experiences that can be utilized in other recombinant protein based therapeutic platforms
•Discuss the role of disease specific biomarkers in predicting the clinical impact of immune responses to recombinant proteins
• Validate methods of patient stratification that focus on those that will be less dependent on immunosuppressives
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment